measures for use in regulatory CEA. The Committee identifies the following areas as priorities for research:
Methods for eliciting societal values for investments in health (such as person trade-off techniques).
Methods for measuring children’s HRQL, including characterization of the impact of illness and injury and the valuation of these impacts.
Methods to correlate QALY values based on different generic HRQL indexes so that estimates from different underlying valuation surveys are consistent and can be used in the same analysis.
Given the substantial impact of major health and safety regulations on the national economy and societal welfare, it is imperative that related decisions be based on high-quality analyses, the results and limitations of which are clearly communicated in a form that is understandable by a wide variety of audiences. Because these rules vary significantly in the type of intervention, the characteristics of the affected population, and the characteristics of the risks addressed, benefit measures are needed that can apply to a broad range of health scenarios. These measures should be supplemented by discussion of any attributes of the scenarios that are not captured in the quantitative measures. Furthermore, the substantial uncertainty that accompanies the risk analysis that underlies the calculation of health-related effects, along with the uncertainty about the preference weighting of QALYs, should be conveyed in sensitivity and uncertainty analyses.
Finally, the process of developing and issuing regulations should be publicly accessible and based on information (including that used in BCA and CEA) that is comprehensible and communicated to a wide audience. Policy makers should facilitate the involvement of affected individuals, populations, and organizations in deliberations about health and safety risks and proposed interventions. Presenting the information for regulatory analysis fully and consistently is an important aspect of an accountable policy process.